HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dior alters ads

This article was originally published in The Rose Sheet

Executive Summary

Christian Dior is revising ads for Dior Addict fragrance by discontinuing the tagline "Admit it" in response to complaints from drug addiction advocacy groups. Company will add statement, "The new perfume from Christian Dior" on ads and will consider integrating "totally devoted to Dior" tagline to clarify message, firm says. Dior also plans to terminate use of certain visuals associated with the marketing campaign. "Parfums Christian Dior has never had any intention to trivialize or glamorize drug abuse or to offend individuals who suffer from or are trying to recover from addictions," President Claude Martinez states in a Jan. 23 letter to the groups. Advocacy groups started campaign against Dior Addict in October (1"The Rose Sheet" Oct. 28, 2002, In Brief)...

You may also be interested in...



Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010951

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel